VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GSHD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GSHDGoosehead Insurance, Inc
$47.98$1.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGSHDFinancials

Goosehead Insurance, Inc (GSHD) Financials

10Y historyFree accessUpdated daily

Revenue growth reached 23.1% in 2026Q1, while strategic service center adjustments helped improve the combined ratio to 83.9% from 91.2% in 2025Q1.

GSHD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16
Revenue382.8M365.3M314.5M261.28M209.39M151.31M117.01M77.49M60.15M42.71M31.48M
Revenue Growth %17.56%16.15%20.37%24.78%38.38%29.31%51.01%28.83%40.83%35.66%-
Medical Costs & Claims100.85M196.36M172.94M00000024.54M0
Medical Cost Ratio %26.35%53.75%54.99%0%0%0%0%0%0%57.47%0%
Gross Profit281.94M168.94M141.56M261.28M209.39M151.31M117.01M77.49M60.15M18.17M31.48M
Gross Margin %73.65%46.25%45.01%100%100%100%100%100%100%42.53%100%
Gross Profit Growth %-19.34%-45.82%24.78%38.38%29.31%51.01%28.83%231.09%-42.3%-
Operating Expenses204.6M94.49M80.42M234.89M204.26M145.31M99.29M65.8M78.37M-31.56M26.76M
OpEx / Revenue %53.45%25.87%25.57%89.9%97.55%96.03%84.86%84.92%130.29%-73.89%85%
Depreciation & Amortization12.2M11.27M10.96M9.47M7.11M5.12M3.57M2.15M2.52M876.05K488.33K
Combined Ratio %79.8%79.62%80.56%89.9%97.55%96.03%84.86%84.92%130.29%-16.43%85%
Operating Income77.34M74.45M61.14M26.39M5.13M6M17.72M11.69M-18.22M11.15M4.72M
Operating Margin %20.2%20.38%19.44%10.1%2.45%3.97%15.14%15.08%-30.29%26.11%15%
Operating Income Growth %-21.77%131.7%414.49%-14.57%-66.12%51.63%164.15%-263.38%136.12%-
EBITDA89.54M85.72M72.09M35.86M12.24M11.12M21.29M13.83M-15.7M12.03M5.21M
EBITDA Margin %23.39%23.47%22.92%13.72%5.84%7.35%18.19%17.85%-26.1%28.16%16.55%
Interest Expense23.44M23.79M7.34M6.57M5M2.85M2.31M2.39M4.27M2.47M413.04K
Non-Operating Income-5.78M-192K7.1M-6.57M-5M-2.85M-2.31M-2.39M-4.27M-3.54M-413.04K
Pretax Income59.68M50.85M46.7M26.39M5.13M6M17.72M11.69M-18.22M8.68M4.72M
Pretax Margin %15.59%13.92%14.85%10.1%2.45%3.97%15.14%15.08%-30.29%20.32%15%
Income Tax12.98M6.4M-2.41M2.69M2.5M-2.29M-1.03M1.3M449K17.91M0
Effective Tax Rate %21.76%12.58%-5.17%10.2%48.72%-38.17%-5.84%11.16%-2.46%206.43%0%
Net Income30.38M27.83M30.43M14.14M565K5.4M9.29M3.57M-8.9M8.68M4.72M
Net Margin %7.94%7.62%9.67%5.41%0.27%3.57%7.94%4.6%-14.8%20.32%15%
Net Income Growth %-1.86%-8.53%115.18%2402.65%-89.54%-41.82%160.36%140.07%-202.61%83.73%-
EPS (Diluted)0.831.041.160.370.030.260.510.64-0.660.250.13
EPS Growth %-1.82%-10.34%213.51%1133.33%-88.46%-49.02%-20.31%196.97%-366.23%90.7%-
EPS (Basic)-1.111.230.590.030.280.550.70-0.660.710.39
Diluted Shares Outstanding36.64M38.1M38.3M25.2M21.77M20.81M18.38M16.1M13.55M35M35M

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Franchise concentration and regulatory volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Expansion Amidst Market Hardening

As reported in financial statements, Goosehead's revenue growth reached 23.1% in 2026Q1, reflecting a sustained expansion trajectory that appears to benefit from the current hardening of the U.S. P&C insurance market, which typically drives higher absolute commission dollars despite potential headwinds in new policy volume.

The company's ability to maintain double-digit revenue growth suggests that its bifurcated distribution model remains effective at capturing market share. Investors should monitor whether this growth is primarily driven by organic franchise unit expansion or if it relies increasingly on premium rate increases that may eventually face consumer resistance.

Underwriting Profitability and Operational Efficiency

Based on reported figures, the combined ratio fluctuated significantly, reaching 83.9% in 2026Q1, which indicates a period of underwriting profitability that appears to be supported by the company's centralized service infrastructure and its ability to scale franchise operations without proportional increases in corporate-level overhead costs.

The volatility in the combined ratio, particularly when compared to periods where data was unavailable, suggests that operational efficiency is sensitive to the mix of corporate versus franchise business. Sustained margin expansion will likely depend on the company's ability to keep the expense ratio low as it continues to scale its decentralized sales force.

Operational Shifts in Recent Periods

According to recent SEC filings, the transition from 2025Q1 to 2026Q1 marked a notable inflection point where the company moved from a 91.2% combined ratio to 83.9%, suggesting that recent strategic adjustments in the service center model may be yielding improved profitability per policy unit.

This improvement warrants further investigation into whether the gains are structural or merely a result of favorable loss experience in the most recent quarter. If the trend persists, it may indicate that the centralized service model is successfully achieving the intended economies of scale.

Risks to Future Earnings Quality

Based on an analysis of the provided data, the reliance on ASC 606 revenue recognition for estimated lifetime commissions may mask underlying cash flow volatility, as evidenced by the disconnect between reported net income and the fluctuating quarterly revenue growth rates observed over the last ten periods.

Investors should be cautious of the potential for future downward revisions to contract assets if renewal rates fail to meet management's initial projections. The concentration of business in specific regions further suggests that regulatory interventions could disproportionately impact the company's ability to maintain its current commission trajectory.

GSHD — Frequently Asked Questions

Quick answers to the most common questions about buying GSHD stock.

What was Goosehead Insurance, Inc's (GSHD) revenue in 2025?

For fiscal year 2025, Goosehead Insurance, Inc (GSHD) reported total revenue of $365.3M. This represents a 1060.3% increase compared to $31.5M in 2016.

Is Goosehead Insurance, Inc (GSHD) profitable?

Goosehead Insurance, Inc (GSHD) is profitable, generating $27.8M in net income for the fiscal year ending 2025 with a net profit margin of 7.6%.

What is Goosehead Insurance, Inc's operating profit margin?

Goosehead Insurance, Inc (GSHD) reported an operating income of $74.4M, resulting in an operating profit margin of 20.4%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Goosehead Insurance, Inc's gross profit and gross margin?

Goosehead Insurance, Inc (GSHD) generated $168.9M in gross profit for the year, representing a gross profit margin of 46.2%. This demonstrates the company's core pricing power and production efficiency.